Natera, Inc. (NTRA)
222.99
+9.52
(+4.46%)
USD |
NASDAQ |
Jun 09, 16:00
222.99
0.00 (0.00%)
After-Hours: 17:46
Natera EPS Diluted (Quarterly) : -0.6013 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -0.3639 |
| CareDx, Inc. | 0.0529 |
| Caris Life Sciences, Inc. | -0.0018 |
| BioRestorative Therapies, Inc. | -0.1215 |
| Exagen, Inc. | -0.1663 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -85.09M |
| Revenue (Quarterly) | 696.64M |
| Total Expenses (Quarterly) | 781.74M |
| Enterprise Value | 29.62B |
| Gross Profit Margin (Quarterly) | 63.90% |
| Profit Margin (Quarterly) | -12.21% |
| Earnings Yield | -0.74% |
| Normalized Earnings Yield | -0.7273 |